Broadfin Capital as of Dec. 31, 2015
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 83 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 11.5 | $187M | 8.6M | 21.67 | |
| iShares Russell 2000 Index (IWM) | 8.0 | $130M | 1.2M | 112.62 | |
| Valeant Pharmaceuticals Int | 6.2 | $102M | 1.0M | 101.65 | |
| Nevro (NVRO) | 5.0 | $81M | 1.2M | 67.51 | |
| SPDR S&P Biotech (XBI) | 4.3 | $70M | 1.0M | 70.20 | |
| Heron Therapeutics (HRTX) | 3.7 | $60M | 2.2M | 26.70 | |
| Retrophin | 3.5 | $57M | 3.0M | 19.29 | |
| Progenics Pharmaceuticals | 3.4 | $55M | 9.0M | 6.13 | |
| Flamel Technologies | 3.3 | $54M | 4.4M | 12.21 | |
| Novadaq Technologies | 3.3 | $53M | 4.2M | 12.74 | |
| Aegerion Pharmaceuticals | 2.5 | $41M | 4.0M | 10.10 | |
| La Jolla Pharmaceuticl Com Par | 1.9 | $32M | 1.2M | 27.00 | |
| AngioDynamics (ANGO) | 1.9 | $30M | 2.5M | 12.14 | |
| Ignyta | 1.9 | $30M | 2.3M | 13.40 | |
| Emergent BioSolutions (EBS) | 1.7 | $27M | 673k | 40.01 | |
| BioDelivery Sciences International | 1.5 | $25M | 5.2M | 4.79 | |
| Teligent | 1.2 | $20M | 2.3M | 8.90 | |
| Aratana Therapeutics | 1.2 | $19M | 3.4M | 5.58 | |
| Recro Pharma | 1.1 | $19M | 2.1M | 9.00 | |
| Medgenics | 1.1 | $18M | 3.0M | 6.02 | |
| AtriCure (ATRC) | 1.1 | $18M | 804k | 22.44 | |
| Pernix Therapeutics Holdings | 1.1 | $18M | 6.1M | 2.95 | |
| Seaspine Holdings | 1.1 | $17M | 1.0M | 17.18 | |
| Advaxis | 1.1 | $17M | 1.7M | 10.06 | |
| Lion Biotechnologies | 1.0 | $16M | 2.1M | 7.72 | |
| Zogenix | 1.0 | $16M | 1.1M | 14.74 | |
| Dynavax Technologies (DVAX) | 0.9 | $15M | 630k | 24.16 | |
| Corium Intl | 0.9 | $15M | 1.8M | 8.12 | |
| Amphastar Pharmaceuticals (AMPH) | 0.9 | $15M | 1.0M | 14.23 | |
| Kempharm | 0.9 | $15M | 732k | 19.86 | |
| Antares Pharma | 0.8 | $14M | 12M | 1.21 | |
| DepoMed | 0.8 | $13M | 726k | 18.13 | |
| Raptor Pharmaceutical | 0.8 | $13M | 2.4M | 5.20 | |
| Egalet | 0.8 | $13M | 1.1M | 11.02 | |
| St. Jude Medical | 0.8 | $12M | 200k | 61.77 | |
| Qlt | 0.7 | $12M | 4.4M | 2.66 | |
| Derma Sciences | 0.7 | $12M | 2.6M | 4.57 | |
| Strongbridge Bioph shs usd | 0.7 | $11M | 1.7M | 6.59 | |
| Redhill Biopharma Ltd cmn | 0.7 | $11M | 830k | 12.88 | |
| Trevena | 0.7 | $11M | 1.0M | 10.50 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.6 | $10M | 4.2M | 2.45 | |
| Paratek Pharmaceuticals | 0.6 | $10M | 530k | 18.97 | |
| Endologix | 0.6 | $9.9M | 1.0M | 9.90 | |
| Alcobra | 0.6 | $9.8M | 1.6M | 6.28 | |
| Idera Pharmaceuticals | 0.6 | $9.6M | 3.1M | 3.09 | |
| Rigel Pharmaceuticals | 0.6 | $9.5M | 3.1M | 3.03 | |
| AMAG Pharmaceuticals | 0.6 | $9.1M | 300k | 30.19 | |
| Cynapsus Therapeutics | 0.6 | $8.9M | 583k | 15.29 | |
| Pernix Therapeutics Hldgs In debt | 0.6 | $9.0M | 16M | 0.58 | |
| Spectranetics Corporation | 0.5 | $8.5M | 565k | 15.06 | |
| Syneron Medical Ltd ord | 0.5 | $8.1M | 1.1M | 7.71 | |
| Amarin Corporation (AMRN) | 0.5 | $7.9M | 4.2M | 1.89 | |
| Adma Biologics (ADMA) | 0.5 | $7.8M | 964k | 8.07 | |
| Mirati Therapeutics | 0.5 | $7.5M | 236k | 31.60 | |
| Biota Pharmaceuticals | 0.4 | $6.8M | 3.5M | 1.94 | |
| Tonix Pharmaceuticls | 0.4 | $6.8M | 891k | 7.67 | |
| Contrafect | 0.4 | $6.7M | 1.4M | 4.75 | |
| Tenax Therapeutics | 0.4 | $6.5M | 2.0M | 3.28 | |
| Ardelyx (ARDX) | 0.4 | $6.3M | 349k | 18.12 | |
| Anthera Pharmaceutcls | 0.3 | $5.4M | 1.2M | 4.64 | |
| Dipexium Pharmaceuticals | 0.3 | $5.2M | 466k | 11.20 | |
| Scynexis | 0.3 | $4.8M | 775k | 6.21 | |
| CAS Medical Systems | 0.3 | $4.6M | 2.6M | 1.77 | |
| Biolinerx Ltd-spons | 0.3 | $4.6M | 3.5M | 1.30 | |
| Mediwound Ltd cmn | 0.3 | $4.5M | 531k | 8.54 | |
| OraSure Technologies (OSUR) | 0.3 | $4.4M | 686k | 6.44 | |
| Genocea Biosciences | 0.3 | $4.5M | 846k | 5.27 | |
| Epirus Biopharmaceuticals In | 0.3 | $4.2M | 1.4M | 3.09 | |
| Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.3 | $4.3M | 1.2M | 3.62 | |
| Fate Therapeutics (FATE) | 0.2 | $3.8M | 1.1M | 3.37 | |
| Protalix BioTherapeutics | 0.2 | $3.4M | 3.3M | 1.02 | |
| Titan Pharmaceutical | 0.2 | $3.4M | 761k | 4.44 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $2.9M | 167k | 17.16 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.1 | $2.5M | 722k | 3.41 | |
| Discovery Laboratories | 0.1 | $2.3M | 11M | 0.21 | |
| Veracyte (VCYT) | 0.1 | $2.2M | 305k | 7.20 | |
| Ampliphi Biosciences | 0.1 | $2.2M | 552k | 3.98 | |
| Rxi Pharmaceuticals | 0.1 | $1.9M | 5.1M | 0.38 | |
| Mela Sciences | 0.1 | $1.4M | 1.3M | 1.11 | |
| Cardica | 0.1 | $1.3M | 8.9M | 0.15 | |
| Ritter Pharmaceuticals | 0.1 | $1.3M | 778k | 1.70 | |
| Palatin Technologies | 0.1 | $903k | 1.4M | 0.66 | |
| Biodel | 0.0 | $680k | 2.0M | 0.34 |
